advertisement
Oncology and Hematology
1049
Episodes 161-176 of 485
- Clinician's Roundtable
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion